These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 30385280

  • 1. Measurement of ceftolozane and tazobactam concentrations in plasma by UHPLC-MS/MS. Clinical application in the management of difficult-to-treat osteoarticular infections.
    Rigo-Bonnin R, Gomez-Junyent J, García-Tejada L, Benavent E, Soldevila L, Tubau F, Murillo O.
    Clin Chim Acta; 2019 Jan; 488():50-60. PubMed ID: 30385280
    [Abstract] [Full Text] [Related]

  • 2. A validated LC-MS/MS method for the simultaneous quantification of the novel combination antibiotic, ceftolozane-tazobactam, in plasma (total and unbound), CSF, urine and renal replacement therapy effluent: application to pilot pharmacokinetic studies.
    Parker SL, Pandey S, Sime FB, Stuart J, Lipman J, Roberts JA, Wallis SC.
    Clin Chem Lab Med; 2021 Apr 27; 59(5):921-933. PubMed ID: 33554515
    [Abstract] [Full Text] [Related]

  • 3. Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination.
    Cho JC, Fiorenza MA, Estrada SJ.
    Pharmacotherapy; 2015 Jul 27; 35(7):701-15. PubMed ID: 26133315
    [Abstract] [Full Text] [Related]

  • 4. Plasma pharmacokinetics of ceftolozane/tazobactam in pediatric patients with cystic fibrosis.
    Arrieta AC, Ang JY, Zhang Z, Larson KB, Yu B, Johnson MG, Rhee EG, Feng EH, Rizk ML.
    Pediatr Pulmonol; 2020 Aug 27; 55(8):2025-2032. PubMed ID: 32421928
    [Abstract] [Full Text] [Related]

  • 5. Population pharmacokinetics of tazobactam/ceftolozane in Japanese patients with complicated urinary tract infection and complicated intra-abdominal infection.
    Kakara M, Larson K, Feng HP, Shiomi M, Yoshitsugu H, Rizk ML.
    J Infect Chemother; 2019 Mar 27; 25(3):182-191. PubMed ID: 30528208
    [Abstract] [Full Text] [Related]

  • 6. Development and validation of a measurement procedure based on ultra-high performance liquid chromatography-tandem mass spectrometry for simultaneous measurement of β-lactam antibiotic concentration in human plasma.
    Rigo-Bonnin R, Ribera A, Arbiol-Roca A, Cobo-Sacristán S, Padullés A, Murillo Ò, Shaw E, Granada R, Pérez-Fernández XL, Tubau F, Alía P.
    Clin Chim Acta; 2017 May 27; 468():215-224. PubMed ID: 28288784
    [Abstract] [Full Text] [Related]

  • 7. Determination of total and free ceftolozane and tazobactam in human plasma and interstitial fluid by HPLC-UV.
    Kratzer A, Schießer S, Matzneller P, Wulkersdorfer B, Zeitlinger M, Schlossmann J, Kees F, Dorn C.
    J Pharm Biomed Anal; 2019 Jan 30; 163():34-38. PubMed ID: 30278324
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of Ceftolozane-Tazobactam during Prolonged Intermittent Renal Replacement Therapy.
    Rawlins M, Cheng V, Raby E, Dyer J, Regli A, Ingram P, McWhinney BC, Ungerer JPJ, Roberts JA.
    Chemotherapy; 2018 Jan 30; 63(4):203-206. PubMed ID: 30304718
    [Abstract] [Full Text] [Related]

  • 9. Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis.
    Gatti M, Raschi E, De Ponti F.
    Eur J Clin Microbiol Infect Dis; 2021 Jun 30; 40(6):1169-1176. PubMed ID: 33415492
    [Abstract] [Full Text] [Related]

  • 10. Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination.
    Sucher AJ, Chahine EB, Cogan P, Fete M.
    Ann Pharmacother; 2015 Sep 30; 49(9):1046-56. PubMed ID: 26160970
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multicenter Evaluation of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Inhibitory Activity against Meropenem-Nonsusceptible Pseudomonas aeruginosa from Blood, Respiratory Tract, and Wounds.
    Grupper M, Sutherland C, Nicolau DP.
    Antimicrob Agents Chemother; 2017 Oct 30; 61(10):. PubMed ID: 28739780
    [Abstract] [Full Text] [Related]

  • 13. Development and validation of a quantitative LC-MS/MS method for the simultaneous determination of ceftolozane and tazobactam in human plasma and urine.
    Putnam WC, Kallem RR, Edpuganti V, Subramaniyan I, Hall RG.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov 30; 1159():122354. PubMed ID: 32905989
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
    Decosterd LA, Mercier T, Ternon B, Cruchon S, Guignard N, Lahrichi S, Pesse B, Rochat B, Burger R, Lamoth F, Pagani JL, Eggimann P, Csajka C, Choong E, Buclin T, Widmer N, André P, Marchetti O.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov 10; 1157():122160. PubMed ID: 32891946
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ceftolozane-tazobactam: A new-generation cephalosporin.
    Cluck D, Lewis P, Stayer B, Spivey J, Moorman J.
    Am J Health Syst Pharm; 2015 Dec 15; 72(24):2135-46. PubMed ID: 26637512
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.